Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
94.30    0.05 (0.05%)
Bid:
94.25
Ask:
94.45
Spread: 0.20 (0.212%)
Market Cap: £1.49b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Trading Statement

2 Oct 2013 07:00

RNS Number : 4822P
Sirius Real Estate Limited
02 October 2013
 



 

 

Sirius Real Estate Limited

("Sirius" or "the Company")

 

Trading Update

Sirius Real Estate Limited is pleased to provide the following update for the six months to 30 September 2013 ("the period").

This has been another good period for the business with the Company expected to be trading in line with management expectations for the first six months of the financial year. Overall demand for space has remained constant from our core SME market which stands to benefit from an improving economic outlook in Germany.

The Company has also made good progress towards completing the refinancing of the group. As announced in August 2013, the Company's major bank facility with Berlin Hannoversche Hypothekenbank AG ('BerlinHyp') of €208m was reduced when Sirius raised long term financing of €52 million through a bond issue secured against four of the assets from the BerlinHyp security pool. Sirius also raised €6.5 million through a share placing to pay down the BerlinHyp debt and permit the release of the four assets. Additionally, we are pleased to announce that the €4m of the bond issue for which Sirius initially subscribed, has now been sold on to third parties. As at 30 September 2013, following the bond issue, share placing and after scheduled amortisation payments, the BerlinHyp loan stood at €149.4 million. We are making good progress on refinancing the remainder of this debt on a long-term basis.

The Company's other loan facility is with ABN AMRO, a part of the Royal Bank of Scotland ('RBS'), which the Company has successfully reduced to €31.3 million, down from €49.2 million as at 31 March 2013. Under a new repayment plan, RBS has agreed, in principle, to extend the entire loan facility to the end of November 2013 on terms similar to previous extensions and has also given Sirius an option to extend the last €5 million of the loan facility until the end of February 2014. The Company intends to repay the outstanding amounts through a combination of refinancing and cash generated from the disposals of non-core properties. The final €5 million loan is expected to be secured against a single asset which is currently being marketed for sale in separate lots.

The Company looks forward to providing a more detailed trading update in December 2013 when it will announce its half yearly results for the six months to 30 September 2013.

 

 

Enquiries:

Sirius

Andrew Coombs, CEO +49 (0)30 285010110

Alistair Marks, CFO

 

Peel Hunt

Capel Irwin +44 (0)20 7418 8900

Hugh Preston

 

Novella Communications

Tim Robertson +44 (0)20 3151 7008

Ben Heath

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBFLLBXBFXFBV
Date   Source Headline
10th Jun 20164:44 pmRNSUpdate on Private and Secondary Placement
9th Jun 20167:00 amRNSProposed Private Placement and Acquisition
27th May 20163:48 pmRNSPosting of Scrip Circular and Reference Price
27th May 20167:00 amRNSDirector/PDMR Shareholding
25th May 20162:00 pmRNSDirector/PDMR Shareholding
23rd May 20167:00 amRNSFinal Results
5th May 20167:00 amRNSUpdate on Funding and Acquisitions
5th Apr 20167:00 amRNSCorrection - Trading Statement
4th Apr 20167:00 amRNSTrading Statement
29th Mar 20167:00 amRNSDirector/PDMR Shareholding
23rd Feb 20165:18 pmRNSHolding(s) in Company
16th Feb 20161:35 pmRNSHolding(s) in Company
15th Feb 20163:07 pmRNSHolding(s) in Company
29th Jan 20167:00 amRNSDirector's Dealing
20th Jan 20167:00 amRNSAdmission of Scrip Shares and Directors' Dealings
15th Jan 20167:00 amRNSScrip Allotment
17th Dec 20153:37 pmRNSResult of EGM
27th Nov 20153:35 pmRNSDirector Dealings
27th Nov 20153:30 pmRNSPosting of Scrip Circular and Reference Price
23rd Nov 20157:00 amRNSHalf Yearly Report
5th Nov 201512:01 pmRNSHolding(s) in Company
3rd Nov 20157:00 amRNSAcquisition update and date of results
23rd Oct 201511:21 amRNSHolding(s) in Company
6th Oct 20157:00 amRNSTrading Statement
11th Sep 20157:00 amRNSDirector/PDMR Shareholding
7th Sep 20157:00 amRNSTrading Update
18th Aug 201512:00 pmRNSDirectors' Dealings
31st Jul 20157:00 amRNSPosting of Annual Report
7th Jul 20154:47 pmRNSHolding(s) in Company
7th Jul 20152:00 pmRNSAllotment of Scrip Dividend
19th Jun 20157:00 amRNSChange of Adviser
17th Jun 20155:48 pmRNSHolding(s) in Company
17th Jun 20157:01 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSHolding(s) in Company
15th Jun 20154:39 pmRNSHolding(s) in Company
11th Jun 20152:00 pmRNSDirector/PDMR Shareholding
8th Jun 20153:29 pmRNSResults of Placing
4th Jun 201511:16 amRNSPlacing and Proposed Acquisition - Replacement
4th Jun 20157:00 amRNSPlacing and Proposed Acquisition
1st Jun 20157:00 amRNSScrip Dividend Reference Price and Conversion Rate
29th May 201511:30 amRNSPosting of Scrip Dividend Alternative Circular
22nd May 20157:00 amRNSFinal Results
13th May 20157:00 amRNSNotice of Results
1st Apr 20157:00 amRNSTrading Statement
27th Mar 20155:00 pmRNSDirectors' Dealings
11th Feb 20157:00 amRNSAcquisition
2nd Feb 20157:00 amRNSEnters FTSE AIM 100
8th Jan 20152:00 pmRNSDirectors' Dealings
2nd Jan 20157:00 amRNSScrip Allotment
22nd Dec 20147:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.